Related Experiment Video
Updated: Jun 15, 2025
03:45
Tracheotomy: A Method for Transplantation of Stem Cells to the Lung
Published on: February 25, 2007
11.7K
Lung cell transplantation for pulmonary fibrosis
Irit Milman Krentsis1, Yangxi Zheng1, Chava Rosen1,2
1Department of Stem Cell Transplantation and Cell Therapy, MD Anderson Cancer Center, Houston, TX, USA.
Science Advances
|August 23, 2024
Summary
Lung cell transplantation shows promise for treating lung fibrosis. This therapy involves transplanting whole lung cell suspensions, effectively reducing fibrosis in mouse models and improving lung function.
Area of Science:
- Regenerative Medicine
- Pulmonary Medicine
- Cell Biology
Background:
- Idiopathic pulmonary fibrosis is a fatal lung disease with limited therapeutic strategies.
- Lung fibrosis progression is linked to a decline in native lung progenitor cells.
Purpose of the Study:
- To investigate the therapeutic potential of whole lung cell transplantation for treating lung fibrosis.
- To evaluate the efficacy of lung cell transplantation in established preclinical models of pulmonary fibrosis.
Main Methods:
- Utilized two mouse models of lung fibrosis: bleomycin-induced and spontaneous (SPC-Cre TRF1 knockout).
- Administered single-cell suspensions derived from entire adult lungs via transplantation.
- Assessed engraftment, cell differentiation, fibrosis attenuation, and lung function post-transplantation.
Main Results:
- Successful engraftment and expansion of donor lung progenitors in both fibrosis models without host conditioning.
- Donor-derived cells differentiated into alveolar type 1 (AT1) and type 2 (AT2) cells, as well as mesenchymal and endothelial cells.
- Significant attenuation of lung fibrosis, confirmed by histological, biochemical, imaging, and functional analyses.
Conclusions:
- Adult lung cell transplantation is a viable therapeutic approach for mitigating lung fibrosis.
- The study establishes lung cell transplantation as a promising strategy for treating pulmonary fibrosis.
